KOD
Kodiak Sciences Inc.
Company overview
- Market capitalization
- $5.65B
- Employees
- 130
- Latest publication
- 2026-09-29
About Kodiak Sciences Inc.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -66,838,000USD | -59,777,000USD | -57,453,000USD | -62,352,000USD | -55,510,000USD | -59,073,000USD | -46,179,000USD | -46,632,000USD |
| Net Income | -65,643,000USD | -58,158,000USD | -56,736,000USD | -61,457,000USD | -54,313,000USD | -57,461,000USD | -44,105,000USD | -43,946,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 26,654,000USD | 0USD |
| Cost Of Revenue | — | 6,340,000USD | -19,805,000USD | 6,539,000USD | 6,538,000USD | 6,728,000USD | 6,682,000USD | 6,697,000USD |
| Gross Profit | — | -6,340,000USD | 19,805,000USD | -6,539,000USD | -6,538,000USD | -6,728,000USD | -6,682,000USD | -6,697,000USD |
| Research Development | — | 48,547,000USD | 45,493,000USD | 50,476,000USD | 42,760,000USD | 43,644,000USD | 31,772,000USD | 31,878,000USD |
| Selling General Administrative | — | 11,230,000USD | 11,960,000USD | 11,876,000USD | 12,750,000USD | 15,429,000USD | 14,407,000USD | 14,754,000USD |
| Total Operating Expenses | — | 59,777,000USD | 57,453,000USD | 62,352,000USD | 55,510,000USD | 59,073,000USD | 39,497,000USD | 39,935,000USD |
| Interest Income | — | 1,641,000USD | 757,000USD | 917,000USD | 1,241,000USD | 1,602,000USD | 2,130,000USD | 2,711,000USD |
| Net Interest Income | — | 1,641,000USD | 757,000USD | 917,000USD | 1,241,000USD | 1,602,000USD | 2,130,000USD | 2,711,000USD |
| Income Before Tax | — | -58,158,000USD | -56,736,000USD | -61,457,000USD | -54,313,000USD | -57,461,000USD | -44,105,000USD | -43,946,000USD |
| Net Income From Continuing Ops | — | -58,158,000USD | -56,736,000USD | -61,457,000USD | -54,313,000USD | -57,461,000USD | -44,105,000USD | -43,946,000USD |
| Ebit | — | -59,777,000USD | -53,032,000USD | -62,352,000USD | -55,510,000USD | -59,073,000USD | -44,105,000USD | -43,946,000USD |
| Ebitda | — | -53,437,000USD | -46,517,000USD | -55,813,000USD | -48,972,000USD | -52,345,000USD | -37,423,000USD | -37,249,000USD |
| Depreciation And Amortization | — | 6,340,000USD | 6,515,000USD | 6,539,000USD | 6,538,000USD | 6,728,000USD | 6,682,000USD | 6,697,000USD |
| Reconciled Depreciation | — | 6,340,000USD | 6,515,000USD | 6,539,000USD | 6,538,000USD | 6,728,000USD | 6,682,000USD | 6,697,000USD |
| Total Other Income Expense Net | — | 1,619,000USD | 717,000USD | 895,000USD | 1,197,000USD | 1,612,000USD | 2,074,000USD | 2,686,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | -6,682,000USD | -6,697,000USD |
| Interest Expense | — | — | — | — | — | — | 0USD | 0USD |
| Income Tax Expense | — | — | — | — | — | — | -6,602,724USD | -43,946,000USD |
| Source | DisclosureVerified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 182,373,000USD | 126,095,000USD | 206,298,000USD | 267,591,000USD | 217,340,000USD | 107,389,000USD | 37,506,000USD | 18,793,000USD |
| Selling General Administrative | 52,015,000USD | 60,754,000USD | 71,023,000USD | 73,788,000USD | 49,711,000USD | 28,618,000USD | 11,684,000USD | 7,581,000USD |
| Total Operating Expenses | 234,388,000USD | 160,143,000USD | 251,374,000USD | 330,378,000USD | 258,339,999USD | 131,799,000USD | 48,279,000USD | 26,374,000USD |
| Operating Income | -234,388,000USD | -186,849,000USD | -277,321,000USD | -341,379,000USD | -267,051,000USD | -136,007,000USD | -49,190,000USD | -26,374,000USD |
| Interest Income | 4,517,000USD | 11,148,000USD | 16,733,000USD | 7,071,000USD | 298,000USD | 2,902,000USD | 1,568,000USD | 3,531,000USD |
| Interest Expense | 0USD | 0USD | 13,000USD | 18,000USD | 22,000USD | 25,000USD | 8,000USD | 5,519,000USD |
| Net Interest Income | 4,517,000USD | 11,148,000USD | 16,720,000USD | 7,053,000USD | 276,000USD | 2,877,000USD | 1,560,000USD | -5,519,000USD |
| Income Before Tax | -229,967,000USD | -176,207,000USD | -260,491,000USD | -333,823,000USD | -266,990,000USD | -133,096,000USD | -47,365,000USD | -41,443,000USD |
| Net Income | -229,967,000USD | -176,207,000USD | -260,491,000USD | -333,823,000USD | -266,990,000USD | -133,096,000USD | -47,365,000USD | -41,443,000USD |
| Net Income From Continuing Ops | -229,967,000USD | -176,207,000USD | -260,491,000USD | -333,823,000USD | -266,990,000USD | -133,096,000USD | -47,365,000USD | -41,443,000USD |
| Ebitda | -234,388,000USD | -149,501,000USD | -234,531,000USD | -322,804,000USD | -258,257,000USD | -128,863,000USD | -46,446,000USD | -35,434,000USD |
| Reconciled Depreciation | 26,320,000USD | 26,706,000USD | 25,947,000USD | 11,001,000USD | 8,711,000USD | 4,208,000USD | 911,000USD | 490,000USD |
| Total Other Income Expense Net | 4,421,000USD | 10,642,000USD | 16,830,000USD | 7,556,000USD | 61,000USD | 2,911,000USD | 1,825,000USD | -15,069,000USD |
| Cost Of Revenue | — | 26,706,000USD | 25,947,000USD | 11,001,000USD | 8,711,000USD | 4,208,000USD | 911,000USD | 490,000USD |
| Gross Profit | — | -26,706,000USD | -25,947,000USD | -11,001,000USD | -8,711,000USD | -4,208,000USD | -911,000USD | -490,000USD |
| Unclassified Operating Expenses | — | -26,706,000USD | -25,947,000USD | -11,001,000USD | -8,711,001USD | -4,208,000USD | — | — |
| Ebit | — | -176,207,000USD | -260,478,000USD | -333,805,000USD | -266,968,000USD | -133,071,000USD | -47,357,000USD | -35,924,000USD |
| Depreciation And Amortization | — | 26,706,000USD | 25,947,000USD | 11,001,000USD | 8,711,000USD | 4,208,000USD | 911,000USD | 490,000USD |
| Income Tax Expense | — | — | — | 7,345,515USD | -153,558USD | 2,729,703USD | -638,000USD | -9,550,000USD |
| Non Operating Income Net Other | — | — | — | 7,574,000USD | 83,000USD | 2,936,000USD | 1,833,000USD | -9,550,000USD |
| Net Income Applicable To Common Shares | — | — | — | -333,823,000USD | -266,990,000USD | -133,096,000USD | -47,365,000USD | -41,443,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 256,811,000USD | 306,006,000USD | 351,533,000USD | 218,069,000USD | 256,725,000USD | 297,909,000USD | 335,578,000USD | 372,669,000USD |
| Cash And Equivalents | 125,903,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 131,358,000USD | 175,258,000USD | 214,816,000USD | 75,728,000USD | 107,919,000USD | 142,685,000USD | 171,936,000USD | 202,493,000USD |
| Other Current Assets | 5,455,000USD | 5,728,000USD | 4,954,000USD | 3,690,000USD | 3,754,000USD | 3,834,000USD | 3,862,000USD | 4,629,000USD |
| Other Non Current Assets | 8,662,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 195,715,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 52,770,000USD | 49,573,000USD | 45,533,000USD | 42,429,000USD | 31,011,000USD | 30,876,000USD | 25,573,000USD | 24,060,000USD |
| Other Current Liabilities | 30,320,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 61,096,000USD | 112,101,000USD | 157,383,000USD | 23,692,000USD | 70,290,000USD | 108,842,000USD | 150,288,000USD | 185,370,000USD |
| Total Equity Including Noncontrolling Interest | 61,096,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 110,607,000USD | 115,887,000USD | 121,864,000USD | 127,482,000USD | 133,961,999USD | 140,376,000USD | 148,730,000USD | 155,252,000USD |
| Accounts Payable | 12,639,000USD | 11,344,000USD | 12,863,000USD | 10,371,000USD | 5,057,000USD | 6,543,000USD | 3,915,000USD | 3,292,000USD |
| Short Term Debt | 9,811,000USD | 11,660,000USD | 12,063,000USD | 11,753,000USD | 11,288,000USD | 10,948,000USD | 10,628,000USD | 10,196,000USD |
| Common Stock | 6,000USD | 6,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Retained Earnings | -1,682,506,000USD | -1,616,863,000USD | -1,558,705,000USD | -1,501,969,000USD | -1,440,512,000USD | -1,386,199,000USD | -1,328,738,000USD | -1,284,633,000USD |
| Total Liab | — | 193,905,000USD | 194,150,000USD | 194,377,000USD | 186,435,000USD | 189,067,000USD | 185,290,000USD | 187,299,000USD |
| Other Current Liab | — | 26,569,000USD | 20,607,000USD | 20,305,000USD | 14,666,000USD | 13,385,000USD | 11,030,000USD | 10,572,000USD |
| Capital Stock | — | 6,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Cash | — | 169,530,000USD | 209,862,000USD | 72,038,000USD | 104,165,000USD | 138,851,000USD | 168,074,000USD | 197,864,000USD |
| Cash And Short Term Investments | — | 169,530,000USD | 209,862,000USD | 72,038,000USD | 104,165,000USD | 138,851,000USD | 168,074,000USD | 197,864,000USD |
| Net Debt | — | -113,538,000USD | -150,682,000USD | -9,837,000USD | -38,953,000USD | -71,212,000USD | -97,729,000USD | -124,429,000USD |
| Short Long Term Debt Total | — | 55,992,000USD | 59,180,000USD | 62,201,000USD | 65,212,000USD | 67,639,000USD | 70,345,000USD | 73,435,000USD |
| Property Plant Equipment Gross | — | 115,887,000USD | 181,336,000USD | 127,482,000USD | 133,962,000USD | 140,376,000USD | 189,992,000USD | 155,252,000USD |
| Common Stock Shares Outstanding | — | 61,859,485shares | 53,208,311shares | 52,859,308shares | 52,779,162shares | 52,746,318shares | 52,650,631shares | 52,616,183shares |
| Non Current Assets Total | — | 130,748,000USD | 136,717,000USD | 142,341,000USD | 148,806,000USD | 155,224,000USD | 163,642,000USD | 170,176,000USD |
| Non Current Liabilities Total | — | 144,332,000USD | 148,617,000USD | 151,948,000USD | 155,424,000USD | 158,191,000USD | 159,717,000USD | 163,239,000USD |
| Non Current Liabilities Other | — | 100,000,000USD | 101,500,000USD | 101,500,000USD | 101,500,000USD | 101,500,000USD | 100,000,000USD | 100,000,000USD |
| Non Currrent Assets Other | — | 14,861,000USD | 14,853,000USD | 14,859,000USD | 8,660,000USD | 8,664,000USD | 8,728,000USD | 8,740,000USD |
| Net Working Capital | — | 125,685,000USD | 169,283,000USD | 33,299,000USD | 76,908,000USD | 111,809,000USD | 146,363,000USD | 178,433,000USD |
| Unclassified Non Current Liabilities | — | 44,332,000USD | 47,117,000USD | 50,448,000USD | 53,924,000USD | 56,691,000USD | 59,717,000USD | 63,239,000USD |
| Unclassified Equity | — | 1,728,952,000USD | 1,716,076,000USD | 1,525,651,000USD | 1,510,792,000USD | 1,495,031,000USD | 1,479,016,000USD | 1,469,993,000USD |
| Unclassified Non Current Assets | — | — | — | — | 6,184,001USD | 6,184,000USD | 6,184,000USD | 6,184,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 351,533,000USD | 335,578,000USD | 479,372,000USD | 666,628,000USD | 904,220,000USD | 1,067,347,000USD | 358,866,000USD | 92,189,000USD |
| Other Current Assets | 4,954,000USD | 3,862,000USD | 3,802,000USD | 7,072,000USD | 3,301,000USD | 3,031,000USD | 2,749,000USD | 4,390,000USD |
| Total Liab | 194,150,000USD | 185,290,000USD | 213,591,000USD | 230,461,000USD | 240,900,000USD | 206,596,000USD | 13,507,000USD | 5,356,000USD |
| Total Stockholder Equity | 157,383,000USD | 150,288,000USD | 265,781,000USD | 436,167,000USD | 663,320,000USD | 860,751,000USD | 345,359,000USD | 86,833,000USD |
| Other Current Liab | 20,607,000USD | 11,030,000USD | 18,351,000USD | 33,440,000USD | 48,319,000USD | 20,402,000USD | 8,658,000USD | 3,776,000USD |
| Common Stock | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD |
| Capital Stock | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD |
| Retained Earnings | -1,558,705,000USD | -1,328,738,000USD | -1,152,531,000USD | -892,040,000USD | -558,217,000USD | -291,227,000USD | -158,131,000USD | -110,766,000USD |
| Cash | 209,862,000USD | 168,074,000USD | 285,507,000USD | 190,433,000USD | 731,510,000USD | 944,396,000USD | 211,797,000USD | 88,254,000USD |
| Cash And Short Term Investments | 209,862,000USD | 168,074,000USD | 285,507,000USD | 478,933,000USD | 731,510,000USD | 968,974,000USD | 336,481,000USD | 88,254,000USD |
| Total Current Assets | 214,816,000USD | 171,936,000USD | 289,309,000USD | 486,005,000USD | 734,811,000USD | 972,005,000USD | 339,230,000USD | 90,449,000USD |
| Total Current Liabilities | 45,533,000USD | 25,573,000USD | 41,729,000USD | 52,496,000USD | 64,683,000USD | 31,422,000USD | 11,711,000USD | 4,826,000USD |
| Net Debt | -150,682,000USD | -97,729,000USD | -103,875,000USD | -2,704,000USD | -551,571,000USD | -866,994,000USD | -209,862,000USD | -88,254,000USD |
| Short Term Debt | 12,063,000USD | 10,628,000USD | 9,770,000USD | 9,926,000USD | 3,933,000USD | 2,374,000USD | 434,000USD | — |
| Short Long Term Debt Total | 59,180,000USD | 70,345,000USD | 181,632,000USD | 187,729,000USD | 179,939,000USD | 77,402,000USD | 1,935,000USD | — |
| Accounts Payable | 12,863,000USD | 3,915,000USD | 13,608,000USD | 9,130,000USD | 12,431,000USD | 8,646,000USD | 2,619,000USD | 1,050,000USD |
| Property Plant Equipment Net | 121,864,000USD | 148,730,000USD | 175,023,000USD | 115,753,000USD | 108,074,000USD | 78,808,000USD | 2,786,000USD | 1,097,000USD |
| Property Plant Equipment Gross | 181,336,000USD | 189,992,000USD | 197,575,000USD | 122,477,000USD | 111,013,000USD | 78,808,000USD | 2,786,000USD | 1,097,000USD |
| Common Stock Shares Outstanding | 53,208,311shares | 52,583,148shares | 52,414,256shares | 52,249,620shares | 51,788,918shares | 45,741,845shares | 37,853,616shares | 35,871,045shares |
| Non Current Assets Total | 136,717,000USD | 163,642,000USD | 190,063,000USD | 180,623,000USD | 169,409,000USD | 95,342,000USD | 19,635,999USD | 1,740,000USD |
| Non Current Liabilities Total | 148,617,000USD | 159,717,000USD | 171,862,000USD | 177,965,000USD | 176,216,999USD | 175,174,000USD | 1,795,999USD | 530,000USD |
| Non Current Liabilities Other | 101,500,000USD | 100,000,000USD | 100,000,000USD | 177,965,000USD | 176,217,000USD | 175,174,000USD | 295,000USD | 530,000USD |
| Non Currrent Assets Other | 14,853,000USD | 8,728,000USD | 8,716,000USD | 58,546,000USD | 55,011,000USD | 16,534,000USD | 5,013,999USD | 503,000USD |
| Net Working Capital | 169,283,000USD | 146,363,000USD | 247,580,000USD | 433,509,000USD | 670,128,000USD | 940,583,000USD | 327,519,000USD | 85,623,000USD |
| Unclassified Non Current Liabilities | 47,117,000USD | 59,717,000USD | 71,862,000USD | — | -100,154,001USD | -100,146,000USD | 1,205,999USD | — |
| Unclassified Equity | 1,716,076,000USD | 1,479,016,000USD | 1,418,302,000USD | 1,329,504,000USD | 1,221,527,000USD | 1,151,915,000USD | 503,470,000USD | 199,276,000USD |
| Unclassified Non Current Assets | — | 6,184,000USD | 6,324,000USD | -58,546,000USD | -55,011,000USD | -68,659,000USD | — | — |
| Short Term Investments | — | — | 0USD | 288,500,000USD | 0USD | 24,578,000USD | 124,684,000USD | — |
| Other Assets | — | — | — | 64,870,000USD | 61,335,000USD | 68,659,000USD | 0USD | 643,000USD |
| Accumulated Other Comprehensive Income | — | — | — | -1,307,000USD | 0USD | 53,000USD | 10,000USD | -1,685,000USD |
| Net Tangible Assets | — | — | — | 436,167,000USD | 663,320,000USD | 860,751,000USD | 345,359,000USD | 86,833,000USD |
| Other Liab | — | — | — | — | 100,154,000USD | 100,146,000USD | 295,000USD | 530,000USD |
| Long Term Investments | — | — | — | — | — | 0USD | 11,696,000USD | — |
| Unclassified Current Assets | — | — | — | — | — | — | — | -2,195,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 8,221,000USD |
| Stock Based Compensation | 23,763,000USD |
| Change To Liabilities | 8,315,000USD |
| Change In Working Capital | -379,000USD |
| Operating Cash Flow | -86,247,000USD |
| Capital Expenditures | -1,294,000USD |
| Investing Cash Flow | -1,294,000USD |
| Financing Cash Flow | 3,582,000USD |
| Change In Cash | -83,959,000USD |
| End Cash Flow | 132,087,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -58,158,000USD | -56,736,000USD | -61,457,000USD | -54,313,000USD | -57,461,000USD | -44,105,000USD | -43,946,000USD | -45,117,000USD |
| Depreciation | 6,340,000USD | -1,477,000USD | 6,539,000USD | 6,538,000USD | 6,728,000USD | 6,682,000USD | 6,697,000USD | 6,681,000USD |
| Stock Based Compensation | 12,155,000USD | 27,331,000USD | 14,046,000USD | 15,641,000USD | 15,891,000USD | 8,619,000USD | 14,810,000USD | 18,375,000USD |
| Other Non Cash Items | -346,000USD | -6,042,000USD | 14,045,999USD | -2,539,000USD | 1,918,000USD | 8,619,000USD | -27,120,000USD | 211,000USD |
| Change In Working Capital | -346,000USD | -2,454,000USD | 7,992,000USD | -2,539,000USD | 3,847,000USD | -1,266,000USD | 1,283,000USD | -6,643,000USD |
| Total Cash From Operating Activities | -40,009,000USD | -39,378,000USD | -32,880,000USD | -34,673,000USD | -29,077,000USD | -30,070,000USD | -21,156,000USD | -26,493,000USD |
| Capital Expenditures | -942,000USD | -43,000USD | -59,999USD | -133,000USD | -270,000USD | -124,000USD | -205,000USD | -49,000USD |
| Free Cash Flow | -40,951,000USD | -39,421,000USD | -32,939,999USD | -34,806,000USD | -29,347,000USD | -30,194,000USD | -21,361,000USD | -26,542,000USD |
| Total Cashflows From Investing Activities | -942,000USD | -43,000USD | -60,000USD | -133,000USD | -270,000USD | -124,000USD | -205,000USD | -260,000USD |
| Total Cash From Financing Activities | 619,000USD | 177,245,000USD | 813,000USD | 120,000USD | 124,000USD | 404,000USD | 0USD | 59,000USD |
| Change In Cash | -40,332,000USD | 137,824,000USD | -32,127,000USD | -34,686,000USD | -29,223,000USD | -29,790,000USD | -21,361,000USD | -26,694,000USD |
| Begin Period Cash Flow | 216,046,000USD | 78,222,000USD | 104,165,000USD | 145,035,000USD | 174,258,000USD | 204,048,000USD | 225,409,000USD | 245,919,000USD |
| End Period Cash Flow | 175,714,000USD | 216,046,000USD | 72,038,000USD | 110,349,000USD | 145,035,000USD | 174,258,000USD | 204,048,000USD | 219,225,000USD |
| Other Cashflows From Financing Activities | 619,000USD | — | 813,000USD | 120,000USD | 124,000USD | 404,000USD | -59,000USD | 59,000USD |
| Investments | — | 0USD | -60,000USD | -133,000USD | -270,000USD | -124,000USD | -205,000USD | -260,000USD |
| Unclassified Operating Cash Flow | — | — | -14,045,999USD | 2,539,000USD | — | -8,619,000USD | 27,120,000USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | 59,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | 355,000USD | -211,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -229,967,000USD | -176,207,000USD | -260,491,000USD | -333,823,000USD | -266,990,000USD | -133,096,000USD | -47,365,000USD | -41,443,000USD |
| Depreciation | 18,328,000USD | 26,706,000USD | 25,947,000USD | 11,001,000USD | 8,711,000USD | 4,208,000USD | 911,000USD | 490,000USD |
| Stock Based Compensation | 58,863,000USD | 60,213,000USD | 88,556,000USD | 106,033,000USD | 61,385,000USD | 30,668,000USD | 6,110,000USD | 2,665,000USD |
| Other Non Cash Items | 9,922,000USD | 355,000USD | -840,000USD | -1,631,000USD | 198,000USD | 49,000USD | -241,000USD | 5,482,000USD |
| Change In Working Capital | 6,846,000USD | -28,386,000USD | -7,355,000USD | 11,961,000USD | 14,426,000USD | 14,794,000USD | 1,439,000USD | -6,392,000USD |
| Total Cash From Operating Activities | -136,008,000USD | -117,319,000USD | -154,183,000USD | -206,459,000USD | -182,270,000USD | -83,428,000USD | -39,146,000USD | -29,031,000USD |
| Capital Expenditures | -506,000USD | -400,000USD | -41,427,000USD | -47,363,000USD | -63,298,000USD | -6,998,000USD | -437,000USD | -581,000USD |
| Free Cash Flow | -136,514,000USD | -117,719,000USD | -195,610,000USD | -253,822,000USD | -245,568,000USD | -90,426,000USD | -39,583,000USD | -29,612,000USD |
| Investments | 0USD | -755,000USD | 249,226,000USD | -289,150,000USD | 24,500,000USD | 111,832,000USD | -136,561,000USD | -581,000USD |
| Total Cashflows From Investing Activities | -506,000USD | -755,000USD | 249,226,000USD | -336,513,000USD | -38,798,000USD | 104,834,000USD | -136,998,000USD | -581,000USD |
| Total Cash From Financing Activities | 178,302,000USD | 501,000USD | 31,000USD | 1,895,000USD | 8,182,000USD | 717,377,000USD | 299,687,000USD | 116,471,000USD |
| Issuance Of Capital Stock | 172,960,000USD | 0USD | 0USD | -241,000USD | 612,321,000USD | 612,016,000USD | 297,616,000USD | 83,755,000USD |
| Change In Cash | 41,788,000USD | -117,573,000USD | 95,074,000USD | -541,077,000USD | -212,886,000USD | 738,783,000USD | 123,543,000USD | 86,859,000USD |
| Begin Period Cash Flow | 174,258,000USD | 291,831,000USD | 190,433,000USD | 731,510,000USD | 950,720,000USD | 211,937,000USD | 88,394,000USD | 1,535,000USD |
| End Period Cash Flow | 216,046,000USD | 174,258,000USD | 285,507,000USD | 190,433,000USD | 737,834,000USD | 950,720,000USD | 211,937,000USD | 88,394,000USD |
| Unclassified Financing Cash Flow | 5,342,000USD | — | — | 9,677,000USD | 9,557,000USD | 612,016,000USD | 297,616,000USD | — |
| Other Cashflows From Investing Activities | — | -755,000USD | 290,653USD | 616,000USD | 24,500USD | -3,184,000USD | -136,561,000USD | -503,000USD |
| Other Cashflows From Financing Activities | — | 501,000USD | -211,000USD | -49,000USD | 8,182,000USD | 112,101,000USD | 4,538,000USD | -176,000USD |
| Unclassified Investing Cash Flow | — | 1,155,000USD | 41,136,347USD | — | — | 3,184,000USD | 136,561,000USD | 1,084,000USD |
| Change To Liabilities | — | — | — | -586,000USD | -2,094,000USD | 16,972,000USD | 6,501,000USD | -4,397,000USD |
| Net Borrowings | — | — | — | 0USD | 0USD | -5,000USD | -48,000USD | 32,752,000USD |
| Dividends Paid | — | — | — | -7,907,000USD | -10,041,000USD | -6,248,000USD | -2,287,000USD | — |
| Sale Purchase Of Stock | — | — | — | 174,000USD | 484,000USD | -487,000USD | -132,000USD | 83,804,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -541,077,000USD | -212,886,000USD | 738,783,000USD | 123,543,000USD | 86,859,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | 10,167,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.